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ABSTRACT 
Antibacterial and antioxidant potentials of Adiantum capillus-veneris, Blumea lacera, Cassia 
alata, and Cisslls quadrangularis from Faridpur, Bangladesh was investigated in this study 
along with their toxicological evaluation. Plant materials were extracted with organic solvents 
(chloroform and methanol) using Soxhlet extractor. Inhibitory action of methanol and 
chloroform extracts of selected plants against three Gram-positive clinical isolates -
Staphylococcus allreus, Bacillus sublilis, Bacillus cereus and three Gram-negative clinical 
isolates - Escherichia coli, Vibrio cholerae, Salmonella typhi was studied using agar disk 
diffusion, agar well diffusion methods. Broth microdilution method was utilized against 
Escherichia coli 0157:H7 strain and clinical isolate of Staphylococcus aureus to define the 
minimum inhibitory concentration of methanol extracts of selected plants. Antioxidant 
potential of methanol extracts of selected plant was studied using DPPH free radical 
scavenging assay. Morphological study of methanol extract treated distal kidney (MDCK) 
cell line revealed the toxicological susceptibility. Investigated plants showed no antibacterial 
activity against the tested clinical isolates. Significant antioxidant activity was demonstrated 
in the methanol extracts of investigated plants. Only Cissus quadrangularis was devoid of 
toxic action in the cytotoxicity assay against MDCK cell line. 
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CHAPTER 1 
INTRODUCTION 
Several diverse lines of evidence indicate that medicinal plants represent the oldest and most 
widespread form of medication. Until the last century most medicines were derived directly 
from plant or animal sources. Despite the increasing use of factory-made synthetic drugs, 
natural organic healing materials have persisted as the "treatment of choice" for a multitude 
of health problems in populations throughout the world [I). 
1.1 Historical Overview of Medicinal Plants 
The healing properties of various plants are recognized and utilized by other primates. A 
number of species of monkeys and apes have been observed to repeatedly consume particular 
botanical species containing chemical components that act as analgesics, anti-microbials, 
anti-inflammatories, immunostimulants, anti -diarrheals, digestive aids, and fertility regulators 
[2-4). A recent review article on this intriguing subject reports that monkeys, gorillas, 
chimpanzees, and humans select some of the same plants for the management of similar 
di seases, injuries, and other health problems [5]. 
There is also ample archaeological evidence indicating that medicinal plants were regularly 
employed by people in prehistoric times. In several ancient cultures botanical products were 
ingested for biomedically curative and psychotherapeutic purposes. Through extensive 
experimentation the biodynamic activities of the phytochemical plant constituents were 
gradually discovered and exploited for specific medical and psychiatric applications. 
Evidence suggests that the early healers were well aware of the mind- body interconnection 
and the important role of patient relaxation in medical treatments and in health restoration 
and rehabilitation [6-8]. In a recent review article Merlin [9] evaluates different lines of 
archaeological evidence regarding psychoactive plant usage in a variety of prehistoric 
cultures in the "Old World" (Eastern Hemisphere). 
Some of the earliest known written records also deal with the subject of healing with 
medicinal substances. The ancient Egyptians of 3000 to 6000 years ago are credited with 
developing an elaborate and effective pharmacological collection of numerous curing 
materials obtained from natural resources. Nunn [10] stated that the most common form of 
treatment recommended in the medical papyri was the use of drugs, drawn from a very wide 
range of animal, mineral, and vegetable substances and administered in a variety of ways. 
The ancient Egyptians were renowned for their skill in this respect. The Egyptian doctors 
prescribed sedatives, analgesics, gastrointestinal disorder remedies, and medicines for urinary 
tract diseases and the common cold [10, II]. Plant extracts were prepared and taken 
internally, applied topically, and administered by fumigation and vapor inhalation. The 
Egyptians are also credited with the early medicinal use of wine, castor oil, marijuana, opium, 
mints, and beer made from barley and wheat [12]. Oakes and Gahlin [II] pointed out that the 
Egyptians were the first people to use a number of drugs that modern studies have proved 
would have been medicinally effective. 
Plant-based therapeutic treatments continued to be augmented later by health-care 
practitioners in ancient Greece 3000 through 1500 years ago. Dioscorides, an authority on 
herbs who lived in the first century A.D., is noted for assembling 24 detailed books on over 
600 curative plants and their proper uses under the title De Materia Medica, the earliest 
known designation of that terminology [13, 14]. 
Following those developments additional discoveries of useful medicinal plants resulted from 
experimentations in several early historic cultures 1000 to 2000 years ago in China, India, 
and Tibet. The herbal specialist was recognized as a powerful and influential professional in 
these societies [12, 15]. About 1000 years ago healers in the Aztec and Maya Indian cultures 
of Mexico and Central America were experimenting with natural curing substances. Evans 
[16] noted that Post-Classic Mesoamericans developed a large and effective pharmacopoeia, 
formulae for medicines concocted from animals, minerals, and especially plants. According 
to Berdan [17], the ancient Aztec healers exploited at least 132 medicinal herbs for the 
treatment of specific ailments ranging from pimples and nosebleeds to gout and epilepsy. 
Respiratory and gastrointestinal infections were addressed with remedies produced from a 
combination of different herbal products, and some of the preparations were prescribed to 
prevent certain diseases. 
Another major advancement was achieved in the 18th century with the revolutionary 
taxonomic work of Swedish naturalist Carolus Linnaeus, whose classifications of thousands 
of botanical species provided the foundation for the standardized documentation of the 
relationships and evolutionary histories of medicinal plants. His classic Systema Naturae 
established the framework for modem biological taxonomy, and his famous works Genera 
Bo/anica and Critica Bo/anica and Philosophica Bo/anica deal with the subject of the precise 
identification of plants and their characteristics, including catalogues with Latin terminology 
of all species known at that time. [n Species Plan/arum Linnaeus recorded detailed 
descriptions of over 5900 plant species. These landmark publications continue to be 
consulted by botanists, herbalists, horticulturalists, and taxonomists. 
Another indication of the lengthy history of botanical medicine is found in its global , cross-
cultural distribution. From its original inception in prehistory, medicinal plant exploitation 
has gradually spread, by both independent discovery and cultural diffusion, to all corners of 
the earth. Organized, systematic collections of traditional herbal remedies have been 
described by anthropologists and ethnobotanists in all countries and ethnic groups surveyed 
so far [18-21]. 
1.2 Significance of Medicinal Plants 
The use of natural products with therapeutic properties is as ancient as human civilization 
and, for a long time, mineral, plant and animal products were the main sources of drugs [22). 
The Industrial Revolution and the development of organic chemistry resulted in a preference 
for synthetic products for pharmacological treatment. The reasons for this were that pure 
compounds were easily obtained, structural modifications to produce potentially more active 
and safer drugs could be easily performed and the economic power of the pharmaceutical 
companies was increasing. Furthermore, throughout the development of human culture, the 
use of natural products has had magical-religious significance and different points of view 
regarding the concepts of health and disease existed within each culture. Obviously, this 
approach was against the new modus vivendi of the industrialized western societies, in which 
drugs from natural resources were considered either an option for poorly educated or low 
income people or simply as religious superstition of no pharmacological value. 
However, even if we only consider the impact of the discovery of the penicillin, obtained 
from micro-organisms, on the development of anti-infection therapy, the importance of 
natural products is clearly enormous. About 25% of the drugs prescribed worldwide come 
from plants, 121 such active compounds being in current use. Of the 252 drugs considered as 
basic and essential by the World Health Organization (WHO), 11 % are exclusively of plant 
origin and a significant number are synthetic drugs obtained from natural precursors. 
Exanlples of important drugs obtained from plants are digoxin from Digitalis spp., quinine 
and quinidine from Cinchona spp. , vincristrine and vinblastine from Catharanthus roseus, 
atropine from Atropa belladonna and morphine and codeine from Papaver somniferum. It is 
estimated that 60% of anti-tumor and anti-infectious drugs already on the market or under 
clinical trial are of natural origin [23]. The vast majority of these cannot yet be synthesized 
economically and are still obtained from wild or cultivated plants. Natural compounds can be 
lead compounds, allowing the design and rational planning of new drugs, biomimetic 
synthesis development and the discovery of new therapeutic properties not yet attributed to 
known compounds [24]. In addition, compounds such as muscarine, physostigmine, 
cannabinoids, yohimbine, forskolin, colchicine and phorbol esters, all obtained from plants, 
are important tools used in pharmacological, physiological and biochemical studies [25]. 
1.2.1 The Search of New Drugs through Ethnomedicine 
The modem social context and economic view of health services, the needs of the 
pharmaceutical market and the recognition that research on medicinal plants used in folk 
medicine represents a suitable approach for the development of new drugs [26] have led to 
an increase in the number of publications in this field, and private and governmental 
institutions are now financially supporting research programs worldwide. 
The NCI (National Cancer Institute, USA) has tested more than 50,000 plant samples for 
anti-HIV activity and 33,000 samples for anti-tumor activity. In 1993, the International 
Program of Co-operation for Biodiversity (IPCB) was launched in order to promote natural 
products in Latin America and Africa, linking universities, industries and governments in a 
multidisciplinary program for the sustained development and preservation of the environment 
[27]. Large pharmaceutical companies, such as Merck, ClBA, Glaxo, Boehringer and Syntex, 
now have specific departments dedicated to the study of new drugs from natural sources [28]. 
However, the potential use of higher plants as a source of new drugs is still poorly explored. 
Of the estimated 250,000- 500,000 plant species, only a small percentage has been 
investigated phytochemically and even a smaller percentage has been properly studied in 
teffi1S of their phaffi1acological properties; in most cases, only phaffi1acological screening or 
preliminary studies have been carried out. It is estimated that 5000 species have been studied 
J 
fo r medical use [29]. Between the years 1957 and 1981 , the NCI screened around 20,000 
plant species from Latin America and Asia for anti-tumor acti vity, but even these were not 
screened fo r other pharmacological activities [24]. 
1.2.2 Advantage over Synthetic Medicine 
In recent years, there has been growing interest in alternative therapies and the therapeutic 
use of natural products, especially those derived from plants [30, 31]. This interest in drugs of 
plant origin is due to several reasons, namely, conventional medicine can be inefficient (e.g. 
side effects and ineffective therapy), abusive and/or incorrect use of synthetic drugs results in 
side effects and other problems, a large percentage of the world 's population does not have 
access to conventional pharmacological treatment, and fo lk medicine and ecological 
awareness suggest that "natural" products are harmless. However, the use of these substances 
is not always authori zed by legal authorities dealing with effi cacy and safety procedures, and 
many published papers point to the lack of quality in the production, trade and prescription of 
phytomedicinal products [32]. 
1.2.3 On the Verge of Extinction 
One of the driving factors fo r the renewed interest in plant antimicrobials in the past 20 years 
has been the rapid rate of (plant) species extinction [33, 34]. There is a fee ling among natural-
products chemists and microbiologists alike that the multitude of potentially useful 
phytochemical structures which could be synthes ized chemically is at risk of being lost 
irretrievab ly [35]. The scientific discipline known as ethnobotany (or ethnopharmacology), 
and animal products they have used to maintain health [36-39], whose goal is to utilize the 
impressive array of knowledge assembled by indigenous peoples about the plant [40] . 
Plant extinctions are occurring at a rate unmatched in geological history, leaving ecosystems 
incomplete and impoverished. Current extinction rates are at least 100 to 1,000 times higher 
than natural background rates, with a quarter of the world 's coniferous trees known to be in 
jeopardy [34] and as many as 15,000 medicinal plants under threat [41]. Over 50% of cycads, 
used medicinally and the oldest seed plants on earth are threatened with extinction. This 
makes them one of the most threatened groups of species currently on the ruCN Red List of 
Threatened Species [42]. 
1.2.4 Challenges in Drug Discovery from Medicinal Plants 
Despite the evident successes of drug discovery from medicinal plants, future endeavors face 
many challenges. Pharmacognosists, phytochemists, and other natural product scientists will 
need to continuously improve the quality and quantity of compounds that enter the drug 
development phase to keep pace with other drug discovery efforts [43]. The process of drug 
discovery has been estimated to take an average of 10 years upwards [44] and cost more than 
800 million dollars [45]. Much of this time and money is spent on the numerous leads that are 
discarded during the drug discovery process. In fact, it has been estimated that only one in 
5000 lead compounds will successfully advance through clinical trials and be approved for 
use. Lead identification is the first step in a lengthy drug development process. Lead 
optimization (involving medicinal and combinatorial chemistry), lead development 
(including pharmacology, toxicology, pharmacokinetics, ADME [absorption, distribution, 
metabolism, and excretion], and drug delivery), and clinical trials all take a considerable 
length of time [46]. 
Up to 1992, the NCr had only found 3 plant extracts active against HIV out of 50,000 tested, 
and only 3 out of 33,000 plant extracts tested were found to have anti-tumour activity [25] . 
Quantitative considerations regarding the average yield of active compounds and the amount 
of starting crude plant material required for the discovery, development and launch of a new 
drug on the market were presented by McChesney [47]: 50 kg ofraw material are necessary 
to provide 500 mg of pure compound for bioassays, toxicology, and "in vivo" evaluation; full 
pre-clinical and clinical studies can require 2 kg of pure compounds obtained from 200 ton of 
raw material [32]. 
At NCI, contracts for the collection of plants that have been operating for nearly 20 years in 
the Americas, Africa, Madagascar, and Southeast Asia were recently suspended due to 
reallocation ofNCI funds for new initiatives aimed at improving diagnosis and prevention, as 
well as expediting the translation of drugs from the development phase to clinical use. In 
addition, as academic pharmacy departments redirect their focus towards the production of 
clinical and community pharmacists, the emphasis on pharmaceutical research and 
development related to medicinal plant and natural product drug discovery in academic 
pharmacy departments is declining [46]. 
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1.2.5 Economic Importance of Medicinal Plants 
Medicinal and aromatic plants (MAPs) are produced and offered in a wide variety of 
products, from crude materials to processed and packaged products like pharmaceuticals, 
herbal remedies, teas, spirits, cosmetics, sweets, dietary supplements, varnishes and 
insecticides [48-50]. The use of botanical raw material is in many cases much cheaper than 
using alternative chemical substances. An estimated number of 70,000 plant species are used 
in folk medicine worldwide [5\). As a consequence, there is an enormous demand in 
botanicals - for domestic use and for commercial trade - resulting in a huge trade on local, 
regional , national and international level. As the production of botanicals sti ll relies to a large 
degree on wild-collection, profound knowledge of trade, size, structure and streams as well as 
of commodities, traded quantities and their origin is essential for assessing its impact on the 
plant populations concerned [52). 
In the period \99\-2003, the reported annual global export of pharmaceutical plants 
amounted on average to 467,000 tonnes valued at US$ 1.2 billion. A main feature the 
international trade is the dominance of only few countries: about 80% of the worldwide 
imports and exports are allotted to only 12 countries each, with the temperate Asian and 
European countries dominating. The countries of temperate Asia are responsible for 41 % of 
the annual global imports and even 48% of the annual global exports. Europe' s share of the 
global import is one third. Regarding single countries the import share of the USA is 12% 
and of Germany and Japan II % each. The list of the world's top 12 countries of import 
shows that Hong Kong is by far the most important importer of pharmaceutical plants with an 
annual average import of approximately 59,950 tonnes. It is followed by the USA with an 
average import of about 5 1,200 tonnes and Japan with 46,450 tonnes a year. Germany 
follows on 4th place, importing on average 44,750 tonnes per year. No fewer than five 
European countries, all of them European Union Member States, are among the top 12 
countries of import. On the export side, China heads the list of the world's top 12 countries of 
export. It exported annually on average about 150,600 tonnes of phannaceutical plants in the 
period \ 99\-2003, which is one third of the total global exportation of pharmaceutical plants. 
This figure is three times as high as the quantities exported from Hong Kong, about four 
times as high as the quantities exported from India and from Mexico, and ten times as high as 
those exported from Germany and the USA. Further important exporters are Egypt, Bulgaria 
and Chile. Two southeast-European countries, Bulgaria and Albania, are amongst the top 12 
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countries of export. From 1991 to 2003 the total world's exports increased by 55% from 
377,300 to 584,700 tonnes [52]. 
1.2.6 Potentials of Medicinal Plants from Bangladesh 
Bangladesh has a great treasure of medicinal plants. Spread over an area of about 55,000 
square miles and endowed by nature with a very favorable climate, Bangladesh possesses 
what is perhaps one of the richest floras of all other areas of a similar size on the surface of 
the globe. A great variety of plants grow in its forests , jungles, wastelands and in the 
roadsides. It is not surprising therefore those plants containing active and medicinal 
principles grow abundantly within its bounds. More than 500 plants growing or available in 
this country have been reported to possess medicinal properties of some description or other 
and have been enumerated in the literature of indigenous drugs [53]. A good number of the 
natural drugs included in different pharmacopoeias grow here; many others can be easily 
grown under cultivation. Almost all these indigenous medicinal plants are extensively used in 
the preparation of Unani, Ayurvedic and Homeopathic medicines in Bangladesh. These 
plants also serve as important raw materials of many modem medicinal preparations. Since 
there has been no systematic phytochemical survey of the medicinal plants of Bangladesh, it 
is quite possible that many other potential medicinal plants in this country still remain 
unexplored and unevaluated. From this rich natural plant resource and the vast array of 
materia medica of the indigenous systems, phytochemical and pharmacological investigations 
and research might bring to the scientific world many useful remedies for alleviation of 
human sufferings. 
Bangladesh imports a large number of vegetable drugs and their extracts from abroad 
spending a huge amount of foreign exchange every year. This foreign exchange could have 
been saved if the indigenous pharmaceutical raw materials could be identified from these vast 
resources and properly processed to render them suitable for use in the pharmaceutical 
industries for the preparation of various pharmaceutical products and for development of new 
drugs. This is what the developed countries do with their natural products and export to other 
countries [54]. 
It is estimated that some 12,500 tonnes of dried medicinal plant material produced in 
Bangladesh is sold. These products are worth some Tk. 255 million ($4.5 million) to the rural 
economy and around Tk. 330 million ($5.8 million) at the factory rate/wholesale. The 5,000 
tonnes of imported medicinal plants cost around Tk 480 million ($8 million). It is believed 
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that there are around 350 inter-district beparis who are serviced by 6,000 to 10,000 local 
collectors, pikers and growers. In total there are said to be around 200 Unani and 200 
Ayuverd ic registered factories, plus some 70 homeopathic factories. Collectively they will 
employ 2,000 to 4,000 people. In addition, there are said to be 5,000 qualified and 80,000 
unqualified herbal practitioners in the country [55). 
1.3 Plant as a Source of Antimicrobials 
Long before mankind discovered the existence of microbes, the idea that certain plants had 
healing potential , indeed, that they contained what we would currently characterize as 
antimicrobial principles, was well accepted. Since antiquity, man has used plants to treat 
common infectious diseases and some of these traditional medicines are still included as part 
of the habitual treatment of various maladies. For example, the use of bearberry 
(Arctostaphylos uva-ursi) and cranberry juice (Vaccinium macrocarpon) to treat urinary tract 
infections is reported in different manuals of phytotherapy, while species such as lemon balm 
(Melissa officinalis), garlic (Allium salivum) and tee tree (Melaleuca alternifolia) are 
described as broad-spectrum antimicrobial agents [56). That being said, it has generally been 
the essential oil s of these plants rather than their extracts that have had the greatest use in the 
treatment of infectious pathologies in the respiratory system, urinary tract, gastrointestinal 
and biliary systems, as well as on the skin. In the case of Melaleuca alternifolia, for example, 
the use of the essential oil (tee tree oi l) is a common therapeutic tool to treat acne and other 
infectious troubles of the skin [57]. 
1.3.1 Major Groups of Antimicrobial Compounds from Plants 
Plants have an almost limitless abi lity to synthesize aromatic substances, most of which are 
phenols or their oxygen-substituted derivatives [58]. Most are secondary metabolites, of 
which at least 12,000 have been isolated, a number estimated to be less than 10% of the total 
[59). In many cases, these substances serve as plant defense mechanisms against predation by 
microorganisms, insects, and herbivores. Some, such as terpenoids, give plants their odors; 
others (quinones and tannins) are responsible for plant pigment. Many compounds are 
responsible for plant flavor (e.g. , the terpenoid capsaicin from chili peppers), and some of the 
same herbs and spices used by humans to season food yield useful medicinal compounds. 
1.3.1.1 Simple Phenols and Phenolic Acids 
Some of the simplest bioactive phytochemicals consist of a single substituted phenolic ring. 
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derived compounds which are in the highest oxidation state. The common herbs tarragon and 
thyme both contain caffeic acid, which is effective against viruses [60], bacteria [61,62], and 
fungi [63]. Catechol and pyrogallol both are hydroxylated phenols, shown to be toxic to 
microorganisms. Catechol has two 20H groups, and pyrogallol has three. The site(s) and 
number of hydroxyl groups on the phenol group are thought to be related to their relative 
toxicity to microorganisms, with evidence that increased hydroxylation results in increased 
tox icity [58] . In addition, some authors have found that more highly oxidized phenols are 
more inhibitory [64, 65]. 
1.3.1.2 Quinones 
Quinones are aromatic rings with two ketone substitutions. In addition to providing a source 
of stable free radicals, quinones are known to complex irreversibly with nucleophilic amino 
ac ids in proteins [66], often leading to inacti vation of the protein and loss of function. For 
that reason, the potential range of quinone antimicrobial effects is great. Probable targets in 
the microbial cell are surface-exposed adhesins, cell wall polypeptides, and membrane-bound 
enzymes. Qui nones may also render substrates unavailable to the microorganism. As with all 
plant-derived antimicrobials, the poss ible tox ic effects of quinones must be thoroughly 
ex ami ned [40]. 
1.3.1.3 Flavones, Flavonoids, and Flavonols 
Flavones are phenolic structures containing one carbonyl group (as opposed to the two 
carbonyls in quinones). The addition of a 3-hydroxyl group yields a flavonol [67]. Flavonoids 
are also hydroxylated phenolic substances but occur as a C6-C3 unit linked to an aromatic 
ring. Since they are known to be synthesized by plants in response to microbial infection 
[68], it should not be surprising that they have been found in vitro to be effective 
antimicrobial substances against a wide array of microorganisms. Their activity is probably 
due to their ability to complex with extracellular and soluble proteins and to complex with 
bacterial cell walls, as described above for quinones. More lipophilic fl avonoids may also 
disrupt microbial membranes [40]. 
1.3.1.4 Tannins 
"Tannin" is a general descriptive name for a group of polymeric phenolic substances capable 
of tanning leather or precipitating gelatin from solution, a property known as astringency. 
Many human physiological activities, such as stimulation of phagocyti c cells, host-mediated 
tumor activity, and a wide range of anti-infective actions, have been assigned to tannins [69]. 
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One of their molecular actions is to complex with proteins through so-called nonspecific 
forces such as hydrogen bonding and hydrophobic effects, as well as by covalent bond 
formation [66, 69]. 
1.3.1.5 Coumarins 
Coumarins are phenolic substances made of fused benzene and a-pyrone rings [70]. Their 
fame has come mainly from their anti thrombotic [71], anti-inflammatory [72] , and 
vasodilatory [73] activities. Several other coumarins have antimicrobial properties. R. D. 
Thomes, working at the Boston Lying-In Hospital in 1954, sought an agent to treat vaginal 
candidiasis in his pregnant patients. Coumarin was found in vitro to inhibit Candida albicans. 
As a group, coumarins have been found to stimulate macrophages [74] , which could have an 
indirect negative effect on infections. 
1.3.1.6 Terpenoids and Essential Oils 
The fragrance of plants is carried in the so called quinta essentia, or essential oil fraction. 
These oils are secondary metabolites that are highly enriched in compounds based on an 
isoprene structure. They are called terpenes, their general chemical structure is CIOH I6, and 
they occur as diterpenes, triterpenes, and tetraterpenes (C2o, C3o, and C40), as well as 
hemiterpenes (C5) and sesquiterpenes (C I5) . When the compounds contain additional 
elements, usually oxygen, they are termed terpenoids. Terpenenes or terpenoids are active 
against bacteria [75-84], fungi [84-90] , viruses [91-95] , and protozoa [96, 97]. In 1977, it was 
reported that 60% of essential oil derivatives examined to date were inhibitory to fungi while 
30% inhibited bacteria [98]. The triterpenoid betulinic acid is just one of several terpenoids 
which have been shown to inhibit HIV. 
1.3.1. 7 Alkaloids 
Heterocyclic nitrogen compounds are called alkaloids. Diterpenoid alkaloids, commonly 
isolated from the plants of the Ranunculaceae, or buttercup family [99], are commonly found 
to have antimicrobial properties [100]. Solamargine, a glycoalkaloid from the berries of 
Solanum khasianum, and other alkaloids may be useful against HIV infection [10 I, 102] as 
well as intestinal infections associated with AIDS [103]. 
1.3.1.8 Lectins and Polypeptides 
Peptides which are inhibitory to microorganisms were first reported in 1942. They are often 
positively charged and contain disulfide bonds [104]. Their mechanism of action may be the 
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formation of ion channels in the microbial membrane [104, 105J or competitive inhibition of 
adhesion of microbial proteins to host polysaccharide receptors [106]. Recent interest has 
been focused mostly on studying anti-HI V peptides and lectins, but the inhibition of bacteri a 
and fungi by these macromolecules, such as that from the herbaceous Amaranthus, has long 
been known [107]. 
1.3.2 Requirement of New Antimicrobials 
It can be argued that the discovery, development and clinical exploitation of antibiotics were 
the most significant medical advances of the twentieth century. It is sobering that at the 
beginning of the twenty-first century articles abound concerning resistance, superbugs and 
the prospects of a post-antibiotic era [108]. Furthermore, the threat of bioterrori sm with 
multi-drug resistant pathogens highlights the need for continued development. With 
hindsight, it is perhaps not surprising that we find ourselves in thi s situation. Complacency 
about the importance of bacteri al infections and a fee ling these had been controlled by the 
development of antibiotics led to a subsequent decline in both academic and industry research 
and a consequent erosion of the knowledge base that now urgently requires to be redressed 
[109]. 
Currently, a more realistic view of the ongoing battle against bacteria prevails: i) there is 
certainty of evolving resistance when antibiotics are used, ii) improvements in medical 
technology result in more patients in critical and immune suppressed states, thus creating a 
perpetual need for new antibiotics. Yet if the development of antibiotics is reviewed it is clear 
that the current rate of discovery is far lower than in the golden age of antibiotics in the 1940s 
through to the 1960s when all the major families of compounds were identified [11O-11 2J. 
There is no doubt that there is a need for new antibiotics, particularly in the hospital setting, 
and the potential of bio-terrori sm should also not be forgotten. The relentless ri se of 
resistance in Gram-positive infections is creating everyday therapeutic challenges III 
managlllg these infections and much effort has been directed towards developing new 
compounds to meet thi s need [113]. However, as the time required to bring an antibiotic from 
discovery to market generally is 8- 12 years, research and development efforts must be 
focused on compounds that will meet not just current needs but those that will be present 10 
years in the future [l14J . Thus while there are a limited number of Gram-positive agents in 
late-stage development the majority of which stem from establi shed classes of antibiotics 
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there is a lack of new antibiotics in development to tackle the return of multi-resistant Gram-
negative pathogens [115]. 
1.4 Plant as a Source of Antioxidants 
The adverse effects of oxidative stress on human health have become a serious issue. The 
World Health Organization (WHO) has estimated that 80% of the earth's inhabitants rely on 
traditional medicine for their primary health care needs, and most of this therapy involves the 
use of plant extracts and their active components [116]. Under stress, our bodies produce 
more reactive oxygen species (ROS) (e.g. , superoxide anion radicals, hydroxyl radicals and 
hydrogen peroxide) than enzymatic antioxidants (e.g., superoxide dismutase (SOD), 
glutathione peroxidase (GPx), and catalase) and non-enzymatic antioxidants (e.g., ascorbic 
acid (vitamin C), tocopherol (vitamin E), glutathione, carotenoids, and flavonoids). This 
imbalance leads to cell damage [117-121] and health problems [122, 123]. A lack of 
antioxidants, which can quench the reactive free radicals, facilitates the development of 
degenerative diseases [124], including cardiovascular diseases, cancers [125] , 
neurodegenerative diseases, Alzheimer's disease [126] and inflammatory diseases [127]. One 
solution to this problem is to supplement the diet with antioxidant compounds that are 
contained in natural plant sources [128]. These natural plant antioxidants can therefore serve 
as a type of preventive medicine. Recent reports indicate that there is an inverse relationship 
between the dietary intake of antioxidant-rich foods and the incidence of human disease 
[129]. 
The oxidative deterioration of fats and oi ls in foods is responsible for rancid odors and 
flavors, with a consequent decrease in nutritional quality and safety caused by the formation 
of secondary, potentially toxic, compounds. The addition of antioxidants is required to 
preserve flavor and color and to avoid vitamin destruction. Among the synthetic types, the 
most frequently used to preserve food are butylated hydroxyanisole (BHA), butylated 
hydroxytoluene (BHT), propyl gallate (PG) and tert-butyl hydroquinone (TBHQ). Reports 
revealing that BHA and BHT could be toxic, and the higher manufacturing costs and lower 
efficiency of natural antioxidants such as tocopherols, together with the increasing 
consciousness of consumers with regard to food additive safety, created a need for identifying 
alternative natural and probably safer sources of food antioxidants [130, 131 ]. The 
replacement of synthetic antioxidants by natural ones may have benefits due to health 
implications and functionality such as solubility 111 both oil and water, of interest for 
emulsions, in food systems. 
The growing interest in the substitution of synthetic food antioxidants by natural ones has 
fostered research on vegetable sources and the screening of raw materials for identifying new 
antioxidants. Oxidation reactions are not an exclusive concern for the food industry, and 
antiox idants are widely needed to prevent deterioration of other oxidisable goods, such as 
cosmetics, pharmaceuticals and plastics [132]. 
Polyphenols represents a large family of compounds having in vitro antioxidant activity. The 
type and amount of polyphenols produced in plants varies greatly depending on genetic 
factors, environmental conditions, germination and degree of ripeness, processing and 
storage. Subdivision of polyphenols into tannins, lignins and flavonoids depends on the 
different phenolic units derived from the plant secondary metabolism pathway [133]. 
The flavonoid family is the major group among the polyphenols, with more than 5000 known 
compounds. Their roles in plants involve pigmentation, enzyme activity regulation, 
protection fTom UV irradiation, chelation of transition metal ion and also reducing activity 
[134]. Flavonoids family includes the catechins, antocyanidines, flavones, flavonols, 
isoflavonols and several other compounds. Important dietary sources of flavonoids are, 
among others, fruits and vegetables (in particular red and purple fruits, red onion, pulses, 
etc.), tea, dark chocolate and red wine. Beneficial effects of flavonoids have been largely 
studied in vitro and in vivo on animal models and small human studies [135]. Results of in 
vitro studies confirm an antioxidant effect of many flavonoid compounds in different 
experimental settings, especially investigating their potential role in the prevention of cancer 
and cardiovascular diseases. Effect of these compounds on animals and humans, though, can 
be strongly affected by the bioavailability of the active compounds, which, in tum, depends 
on several factors , such as their release from the food matrices, modifications and 
degradations they can undergo during the digestive process, and their abi li ty to reach cellular 
targets [136]. 
Another group of antioxidant compounds widely diffused in plants is the carotenoids. They 
belong to the family of fat-soluble tetraterpenoids and occur naturally in chloroplasts of plant 
and algae and also in some types of fungi and bacteria [137]. Plant and algae use carotenoids 
to absorb light energy to use during photosynthesis and to protect chlorophyll fTom light 
damage. Carotenoids can be classified into carotenes (oxygen-free molecules) and 
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xanthophylls (containing oxygen). Alpha-, beta- and gamma-carotenes and beta-
cryptoxantine are all dietary carotenoids that have vitamin A activity in humans (Britton, 
1995). Carotenes takes their name from the most well-known member of this group, carotene, 
found in carrot and other orange colored fruits and vegetables [138]. The colors of 
carotenoids range from pale yellow (xanthophylls) to deep red (e.g. Iycopene, abundant in 
tomato fruits). A high intake of carotenoidrich foods has been correlated with a decreased 
incidence of serious chronic diseases. However, a recent metaanalysis of several in vivo 
clinical supplementation trials have indicated an increased incidence of death in smoker 
patients assuming beta-carotene supplements, suggesting a potential harmful effect for this 
compound, assumed alone and not as a diet component [139]. Human's intake of carotenoids 
depends entirely on the diet. 
Vegetable oils, nuts and wholegrain cereals are all good dietary sources of tocopherols, 
organic compounds with vitamin E activity [140]. Alpha- and gammatocopherol are the main 
dietary sources of vitamin E. As tocopherols are present in oils, a very low-fat diet could 
decrease the intake of vitamin E, also considering that its absorption is best when associated 
with consumption of meals [141]. Tocopherols are often used, along with other antioxidants, 
to preserve food itself from oxidation, especially oil s from going rancid. Many studies 
investigated the effects of vitamin E supplementation, and antioxidants are today available on 
the market as dietary supplements, alone or in combination with other bioactive molecules. 
Integration of the diet with vitamins and other micronutrients supplements can be beneficial, 
but can also represent a risk [133]. 
1.5 Potential Risk Associated with Medicinal Plants 
A general disillusionment with conventional medicines, coupled with the desire for a 'natural' 
lifestyle has resulted in an increasing utilization of complementary and alternative medicine 
across the developed world. Herbal medicinal products are being used increasingly by the 
general public on a se lf-selection basis to either replace or complement conventional 
medicines. 
As with all fom1s of self-treatment, the use of herbal medicinal products presents a potential 
risk to human health [142, 143]. There are concerns that the patient may be exposed to 
potentially toxic substances either from the herbal ingredients themselves or as a result of 
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or cause a patient to abandon conventional treatment without first seeking appropriate advice. 
Emerging evidence suggests that herbal medicinal products may in some cases compromise 
the efficacy of conventional medicines, for example through herb-drug interactions. 
The safety of herbal medicinal products is of particular importance as the majority of these 
products is self-prescribed and is used to treat minor and often chronic conditions. The 
extensive traditional use of plants as medicines has enabled those medicines with acute and 
obvious signs of toxicity to be well recognized and their use avoided. However, the premise 
that traditional use of a plant for perhaps many hundreds of years establishes its safety does 
not necessarily hold true [142-144]. The more subtle and chronic forms of toxicity, such as 
carcinogenicity, mutagenicity and hepatotoxicity, may well have been overlooked by 
previous generations and it is these types of toxicities that are of most concern when 
assessing the safety of herbal remedies. 
A UK Medical Toxicology Unit conducted a study of potentially serious adverse reactions 
associated with exposure to traditional medicines and food supplements during 1991 to 1995 
[145]. Of 1297 enquiries from healthcare professionals, a total of785 cases were identified as 
possible (n = 738), probable (n = 35) or confirmed (n = 12) cases of poisoning caused by 
traditional medicines or food supplements. The report concluded that the overall ri sk to 
public health from these types of products was low. However, clusters of cases were 
identified that gave cause for concern. Twenty-one cases of liver toxicity, including two 
deaths, were associated with the use of traditional Chinese medicines, although no causative 
agent was identified. 
Potential hepatotoxicity associated with herbal medicines has been discussed for some time 
[146, 147). Hepatotoxicity has been reported with a number of herbal medicines. Teucrium 
species have also been implicated in hepatotoxicity. Following reports of serious cases of 
liver toxicity associated with the use of Piper melhyslicum, P. melhyslicum has been 
prohibited in unlicensed medicinal products in the UK since January 2003 [148]. 
In 2007, MHRA was aware of 79 cases of liver damage associated with the consumption of 
kava that have been reported worldwide. 
1.5.1 In vitro Assessment of General Toxicity 
Traditionally, animal testing has always played an important role in the safety evaluation of 
such agents. However, financial and ethical considerations, together with an increased 
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awareness of the limitations of animal models in relation to human metabolism, now warrant 
the development of alternative testing methods. Therefore, it is fitting that the potential of 
biotechnology should provide mammalian cell systems for in vitro testing. The ultimate aim 
of in vitro toxicity testing is the replacement of animals in testing protocols, but in the short 
term, procedures are refined to reduce the numbers of animals required. This "three Rs" 
philosophy of reduction, refinement, and replacement was first proposed by Russell and 
Burch as early as 1959 [149], and is now recognized in the UK Animals in Scientific 
Procedures Act, 1986 and EC Directive 86/609IECC [150]. 
Cytotoxicity is considered primarily as the potential of a compound to induce cell death. 
Most in vitro cytotoxicity tests measure necrosis. Furthermore, detai led studies on dose and 
time dependence of toxic effects to cells, together with the observation of effects on the cell 
cycle and their reversibility, can provide valuable information about mechanisms and type of 
toxicity, including necrosis, apoptosis or other events. In vitro cytotoxicity tests are useful 
and necessary to define basal cytotoxicity, for example the intrinsic abi lity of a compound to 
cause cell death as a consequence of damage to basic cellular functions. Cytotoxicity tests are 
also necessary to define the concentration range for further and more detailed in vitro testing 
to provide meaningful information on parameters such as genotoxicity, induction of 
mutations or programmed cell death [151]. 
Over the last two decades there has been considerable interest in using basal cytotoxicity data 
to predict the acute effects of compounds in vivo . If a compound is acutely toxic, it is 
anticipated that, in most cases, this reflects an insult to the intrinsic functions of cells. This 
approach has been successfully applied in a validated in vitro method to assess phototoxicity 
[152] , based on ATP-dependent neutral red uptake into Iysosomes [153]. In a large study ofa 
diverse range of chemicals, a reasonably good correlation was found between basal 
cytotoxicity and acute toxicity in animals and humans. Kinetic factors and target organ 
specificity of the toxic effect are major parameters compromising the correlation. For this 
reason basal cytotoxicity should be considered as a starting point in an integrated assessment 
of potential in vivo toxicity of food chemicals [151] . 
1.6 Profiles for Investigated Medicinal Plants 
1.6.1 Adiantum capillus-veneris 
Table 1.1 Taxonomic Hierarchy of Adiantum capillus-veneris 
Kingdom 
Subkingdom 
Division 
Class 
Order 
Family 
Genus 
Species 
Plantae -- Planta, plantes, plants, Vegetal 
Tracheobionta -- vascular plants 
Pteridophyta 
Filicopsida 
Polypodiales 
Pteridaceae 
Adiantum L. -- maidenhair fern 
Adiantum capillus-veneris L. -- common maidenhair, common 
maidenhair fern , venus hairfern 
1.6.1.1 Description 
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A tufted fern. Stipes wiry, suberect, 10-23 cm long, polish, blackish; fronds bipinnate, with a 
short terminal pinna and numerous erect-patent lateral ones on each side, the lowest slightly 
branched again; segments 1.25-2.5 cm broad, the base cuneate, the outer edge rounded, 
deeply lobed; sori roundish or obreniform, placed in the roundish sinuses of the crenations 
[ 154]. 
1.6.1.2 Distribution 
Adiantum capillus-veneris is native to the southern half of the United States from California 
to the Atlantic coast, through Mexico and Central America, to South America. It is also 
native to Eurasia, the Levant in Western Asia, and Australasia. 
It is found in temperate climates from warm-temperate to tropical , where the moisture content 
is high but not saturating, in the moist, well-drained sand, loam or limestone many habitats, 
including rainforests, shrub and woodlands, broadleaf and coniferous forests , and desert cliff 
seeps, and springs. It will often be seen growing on sheltered and shaded south-facing 
limestone formations, kept moist by moving water [155] . 
1.6.1.3 Uses 
In the Peruvian Amazon, local people prepare the fronds of the plant as an infusion or syrup 
and use it as a diuretic, as an expectorant and to calm coughs, to promote perspiration and 
menstruation, and to treat unnary disorders, colds, rheumatism, heartburn, gallstones, 
alopecia (hair loss), and sour stomach. In the highlands of the Peruvian Andes, local shamans 
and healers decoct the rhizome and use it for alopecia, gallstones, and jaundice. In the 
Brazilian Amazon, it is recommended as a good expectorant and used for bronchitis, coughs, 
and other respiratory problems. 
Adiantum capillus-veneris has long held a place in herbal medicine systems worldwide. In 
European herbal medicine, its documented use predates the era of Dioscorides and Pliny (23-
79 A.D.). Culpepper (1787 ed.) said, "This and all other Maiden Hair Ferns is a good remedy 
for coughs, asthmas, pleurisy, etc., and on account of its being a gentle diuretic also in 
jaundice, gravel and other impurities of the kidneys." In France, the fronds and rhi zomes 
were once made into a syrup called "Sirop de Capillaire," which was a favorite medicine for 
upper respiratory problems such as coughs and excessive mucus. The plant is also used 
widely throughout the world for dandruff, hair loss, and menstrual difficulties. 
In Brazilian herbal medicine today, the frond and leaf are employed for hair loss, coughs, 
bronchitis, laryngitis and throat dryness, and to improve appetite and digestion, stimulate 
renal function, regulate menstruation, and facilitate childbirth. In Peruvian herbal medicine, 
the frond and rhi zome are used for hair loss, gallstones, hepatic calculi, hydrophobia, asthma, 
coughs, catarrh, and to regulate menstruation. In India, the entire plant is used for its cooling 
effects, for diabetes, colds, bronchial disease, and for its menstrual promoting properties. 
Externally it is used for boils, eczema, and wounds [155]. 
1.6.1.4 Chemical Constituents 
Chemical analysis of Adiantum capillus-veneris reveals an array of compounds including 
triterpenes, flavonoids, phenylpropanoids, and carotenoids. Interestingly, despite its ancient 
use, there has been no specific research on Adiantum capillus-veneris to isolate and test its 
chemicals for biological activities. 
Adiantone, adiantoxide, astragalin, beta-sitosterol , caffeic acids, caffeylgalactose, 
caffeylglucose, campesterol, carotenes, coumaric acids, coumarylglucoses, diplopterol , 
epoxyfilicane, fernadiene, fernene, filicanes, hopanone, hydroxy-adiantone, hydroxy-
cinnamic acid, isoadiantone, isoquercetin, kaempferols, lutein, mutatoxanthin, naringin, 
neoxanthin, nicotiflorin, oleananes, populnin, procyanidin, prodelphinidin, quercetins, 
querciturone, quinic acid, rhodoxanthin, rutin, shikimic acid, violaxanthin, and zeaxanthin are 
chemicals found in Adiantum capillus-veneris [155]. 
1.6.2 Blumea lacera 
Table 1.2 Taxonomic Hierarchy of BII/mea lacera 
Kingdom Plantae -- Planta, plantes, plants, Vegetal 
Subkingdom Tracheobionta -- vascular plants 
Division Magnoliophyta -- angiospermes, angiosperms, flowering plant 
Class Magnoliopsida -- dicots, dicotyledones, di cotyledons 
Subclass Asteridae 
Order Asterales 
Family Asteraceae -- sunflowers, toumesols 
Genus Bll/mea DC. -- false oxtongue 
Species Bll/mea lacera (Burm. f.) DC. -- blumea 
1.6.2.1 Description 
An erect, villous, foetid herb. Lower leaves petioled, often incised or lyrate, the upper 
subsessile elliptic oblong or obovate, finely silky pubescut. Heads 8 mm across, numerous in 
short axillary cymes and terminal spicifo rm panicles; fl owers yellow [156]. 
1.6.2.2 Distribution 
The plant occurs throughout the plains of India from the north-west ascending to 2,000 ft in 
the Himalayas. It is a common roadside weed in Ceylon and Malaya. It is distri buted to the 
Malay Islands, Australia, China and Tropical Africa. Blumea consists of about 80 species. 
Blumea lacera competes with rabi crops such as linseed, chickpea, and wheat for light, food 
and moisture and harbors diseases and insects such as Eup1exia dolorosa, Eublemma 
trifas iciata [1 57). Grow as a weed in fallow lands all over Bangladesh [156]. 
1.6.2.3 Uses 
Leaf juice is used as astringent, febrifuge , anthelmintic and diuretic; is also used to prepare an 
astringent eye lotion. The juice mixed with black pepper is given in piles . The plant also acts 
as a good stomachic, antispasmodic and diuretic. Alcoholic extract of the herb exhibited anti -
inflammatory activity against carrageenan and bradykinin-induced inflammation in rats. 
Essential oils from leaves possess antimicrobial properties, R: astringent, fe brifuge and it is 
used in cholera when mixed with pepper [1 56]. 
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1.6.2.4 Chemical Constituents 
Various parts of the plant yield an essential oil containing cineol, fenchone and camphor. 
Leaves also contain coni feryl alcohol derivatives, camp sterol and fl avonoid. Ethano l extract 
of aerial parts contains hentriacontane, hentriacontanol, lupeol and its acetate and beta 
sitosterol. Root and root bark contain triterpenes, phenolic glycosides and sterols [54]. 
1.6.3 C:assia alala 
Table 1.3 Taxonomic Hierarchy of Cassia alata 
Kingdom 
Subkingdom 
Division 
Class 
Subclass 
Order 
Family 
Genus 
Species 
Plantae -- Planta, plantes, plants, Vegetal 
Tracheobionta -- vascular plants 
Magnoliophyta -- angiospermes, angiosperms, flowering plants, 
Magnoliopsida -- dicots, dicoty ledones, dicotyledons 
Rosidae 
Fabales 
Fabaceae 
Cassia P. Mill. -- cass ia 
Cassia alala (L.) Roxb. -- emperor's candlesticks 
1.6.3.1 Description 
An erect glabrous or subglabrous shrub of 3-8 ft. ; stem terete, smooth, glabrous, or minutely 
puberulous. Leaves from 1-2 or 3 ft . in length, rachis acutely margined above when dry, 
glandular with a prominent transverse ridge connecting the opposite leaflets; leaflets in 9-1 2 
pairs, very broadly oblong elliptic-oblong or the upper larger leaflets obovate-elliptical, 
rounded above and very obtuse or retuse, mucronate, base obl ique truncate or subcordate at 
least as to the lower margin, glabrous, firmly membranous; the larger leaflets varying from 3-
7 in. in length, subsessile or petiolules I line. Stipules obliquely triangular, acute, broad-
based, persistent. Flowers in long erect axillary or apparently terminal stoutly pedunculate 
racemes. Bracts coloured, ovate or ell iptical, obtuse or broadly pointed, imbricating at first, 
earl y deciduous, 112-1 in. long. Pedicels 1/4- 112 in. Sepals coloured membranous, nearly 
equal in length. Two anterior stamens with enlarged strongly curved anthers about 5 lines 
long. Legume 2-valved, thinly but firml y coriaceous, linear apiculate, 5-6 in. long, 1/2- 3/4 
in. broad, each valve with a very prominent crenate longitudinal wing extending the entire 
length of the valve and incurved towards the ventral suture. Seeds rhomboid-cuneate, 
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compressed; cotyledons sigmoid, in transverse section occupying the median third or half of 
the seed [1 58]. 
1.6.3.2 Distribution 
It is native to the Amazon Rainfo rest and can be found in Peru, Brazil, French Guiana, 
Guyana, Suriname, Venezuela and Colombia. Due to its beauty, it has been cultivated around 
the world as an ornamental plant and has naturali zed in many tropical regions in the world 
including tropical Africa, tropical Asia, Australia, Mexico, the Caribbean, Melanesia, 
Polynesia, & Hawaii [1 59]. In Bangladesh, it grows wild in all di stricts of the country [54]. 
1.6.3.3 Uses 
The Tikuna Indians of the Amazon prepare a decocotion of the flowers as a purgati ve and one 
cup is taken each morning. In Cuba, the plant is named guacamaya francesa and it is used for 
herpes ulcers and other skin conditions, as a diuretic and as a laxative. In Peruvian herbal 
medicine systems the plant is called retama and the flowers are prepared in an infusion to 
treat urinary infections and used to increase urination; the leaves and stems are prepared in a 
decoction for acaries, herpes ulcers, ringworm, and other skin conditions; and , the root, 
leaves, wood and fl owers are decocted for a remedy against intestinal parasites and hepatiti s. 
Interestingly, the flowers are used as a diuretic (to increase urination), while the leaves are 
believe to be anti-diuretic . In Brazil , the plant is called guajava or mata-pasto. An infusion of 
the bark and roots is used for hydropsy, skin erruptions and fever. The leaves are considered 
an ememmagogue and diuretic and are prepared in extracts or capsules fo r liver problems, 
anemia, dyspepsia, menstrual problems, and high fevers. The leaves are juiced and mixed 
with lemon juice and applied to the skin fo r dermatitis and taken internally for syphilis [1 59]. 
1.6.3.4 Chemical Constituents 
Cassia plant contains a group of chemicals called anthraquinones. These chemicals are well 
known for their laxative effect. Guajava leaves also contain a chemical called adenine which 
has been documented as an effective platelet aggregating inhibitor (reduces sticky blood and 
arterial plaque). 
Other chemicals in guaj ava include chrysoeriol-7-0-(2"-O-beta-D-mannopyranosyl)-beta-D-
allopyranoside, kaempferol , kaempferol 3-0-gentiobioside, naringenin, quercetin, and 
rhamnetin-3-0-(2" -O-beta-D-mannopyranosyl)-beta-D-allopyranoside [159]. 
1.6.4 Cissus quadrangularis 
Table 1.4 Taxonomic Hierarchy of CisslIs qlladrallglllaris 
Kingdom Plantae - Plants 
Subkingdom Tracheobionta - Vascular plants 
Division Magnoliophyta - Flowering plants 
Class Magnoliopsida - Dicotyledons 
Subclass Rosidae 
Order Rhamnales 
Family Vitaceae - Grape family 
Genus Cissus L. - treebine 
Species Cissus quadrangularis L. - veldt-grape 
1.6.4.1 Description 
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Cissus quadrangularis reaches a height of 1.5 m and has quadrangular-sectioned branches 
with internodes 8 to 10 cm long and 1.2 to 1.5 cm wide. Along each angle is a leathery edge. 
Toothed trilobe leaves 2 to 5 cm wide appear at the nodes. Each has a tendril emerging from 
the opposite side of the node. Racemes of small white, yellowish, or greenish flowers; 
globular berries are red when ripe [160]. 
1.6.4.2 Distribution 
It is probably native to India or Sri Lanka, but is also found in Africa, Arabia, and Southeast 
Asia. It has been imported to Brazil and the southern United States [160J. It grows in the 
Sundarbans of Bangladesh and occasionally planted in the gardens in others areas. 
1.6.4.3 Uses 
Has been used as a medicinal plant since antiquity. The siddha medicine mentions it as a 
tonic and analgesic, and prescribes its use to help heal broken bones, thus its name 
asthisamharaka (that which prevents the destruction of bones). Has also been used to treat 
osteoporosis, asthma, cough, hemorrhoids, and gonorrhea. In the traditional medicinal 
systems of India it has been reported to possess not only bone fracture healing, but also It is 
said to have antibacterial, antifungal, antioxidant, anthelmintic, anti hemorrhoidal and 
analgesic activities [161]. It contains a rich source of carotenoids, triterpenoids and ascorbic 
acid. Compounds that act as receptor antagonists of glucocorticoids have reduced the healing 
time of broken bones 30 to SO percent in clinical trials. It has also been used to treat obesity 
and associated oxidative stress [162]. Its bactericidal effects on Helicobacter pylori hold 
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promise as an effective treatment of gastric ulcers and preventative of stomach cancer in 
conjunction with NSAID therapy [163]. A weight loss supplement containing Cissus 
quadrangu/aris with several dietary supplements (green tea, soy, selenium, chromium,and B 
vitamins) was evaluated in an 8-week clinical trial. The supplement helped reduce body 
weight by 4-8% (placebo 2.4%) a clinically significant weight loss [164]. 
1.6.4.4 Chemical Constituents 
The herb contains an oxo-steroid, having fracture healing action similar to that of durabalin, 
3-ketsteroid and other principles and also contains carotene, beta sitosterol, ascorbic acid and 
calcium oxalate [54]. 
1. 7 Study Rationale 
Although there has been a relentless increase in resistance to antimicrobial agents amongst 
important bacterial pathogens throughout the world, it is well known that the number of new 
antimicrobial agents being brought to the market has undergone a steady decline in the past 
several decades. Since antiquity, man has used plants to treat common infectious di seases and 
some of these traditional medicines are still included as part of the habitual treatment of 
various maladies [165]. The antimicrobial compounds from plants may inhibit bacterial 
growth by different mechanisms than those presently used antimicrobials and may have a 
significant clinical value in treatment of resistant microbial strains [166]. The current study 
will contribute to the pursuit and development of new antimicrobial. 
There is a growing interest in natural antioxidants plants because of the worldwide trend 
toward the use of natural additives in food and cosmetics. Plants are one of the most 
important targets to search for natural antioxidants from the point of view of safety [167]. 
The study will contribute towards the growing database of knowledge on herbal medicines 
and help to advocate the safe and effective use of traditional herbal remedies. The di scovery 
of medicinal plants in different parts of the world is also important both to the agricultural 
and medicine sectors, helping in establishment of new directions towards propagation of 
alternative medicinal crops that offer better economic and social benefits. 
1.8 Major Aim and Objectives 
The major aim of the proposed study was to investigate the antibacterial, antioxidant potential 
and to execute toxicological evaluation of crude extracts of the four plants used in traditional 
medicine - Adiantum capillus-veneris, Blumea lacera, Cassia alata, and Cissus 
quadrangularis 
The first specific objective was to assess the biological activity of the selected plants' extracts 
against clinical isolates of three Gram-positive - Staphylococcus aureus, Bacillus sublilis, 
Bacillus cereus and three Gram-negative - Escherichia coli, Vibrio cholerae, Salmonella 
typhi species using agar disk diffusion, agar well diffusion and broth microdilution methods. 
The second speci fic objective was to evaluate the antioxidant capability of methanol extracts 
of designated plants using DPPH free radical scavenging assay. 
The third specific objective was to investigate the potential toxicity of methanol extracts of 
selected plants by assessing their cytotoxicity against in vitro cultures of MDCK cell line. 
1.9 Hypothesis 
The working hypothesis was that four medicinal plants for this study have some potential 
antioxidant, antibacterial commotion with the deficiency for potential toxicity and depending 
on the activities, will possibly lead to the development of alternate new therapeutic 
modalities. 
CHAPTER 2 
MA TERIALS and METHODS 
2.1 Plant Extract Preparation 
2.1.1 Collection and Identification of Plant Materials 
Four plants were used for the current study - Adiantum capillus-veneris, Blumea lacera, 
Cassia a/ata and Cissus quadrangularis. Leaves of Adiantum capillus-veneris, Blumea 
lacera, Cassia alala and whole plant of Cissus quadrangularis were collected in air tight 
polythene bag from different locations of Faridpur in January, 2010 and the incidence was 
recorded. The plant materials were identified by the Bangladesh National Herbarium, Dhaka, 
Bangladesh. 
2.1.2 Preparation of Plant Materials 
Collected fresh plant materials were examined and old, insect and fungus infected leaves 
were removed. For effective drying the collected leaves were kept in open mesh bag and kept 
apart from individual plants. Plant materials were placed in diffused sunl ight for 60 days until 
they were thoroughly dried. Dried plant materials were minced to fine powder using 
laboratory blender with occasional shaking and kept in air tight polyethylene bags in the dark 
until extraction. 
2.1.3 Extraction of Plant Materials with Chloroform 
Air-dried and powdered plant materials were extracted with chloroform (CH3Cl,) USIng 
Soxhlet extractor (Glasscolabs, UK). The Soxhl et extraction procedure is a semicontinuolls 
process, which has been found to yield an optimal extraction of similar products [168). The 
protocol fo llowed was the standard method of extraction published by Current Protocols 
[169).30 g of each of powdered plant materials were weighed into extraction chamber. Plant 
material was extracted with 400 ml chloroform at the boiling point (61 0 C) using a heating 
mantle. The condensation rate for the chloroform was set at about 100-120 drops per minute 
and the extraction was continued for 6 hours. After the extraction the extract was allowed to 
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cool and filtered with Whatman grade I : II !lm cellulose filter paper. Fi ltered extract was 
concentrated by using a hot plate at low temperature (40-50° C). Dried extract was weighed 
and expressed in percentage of original sample. All extracts were stored at 4° C until used. 
2.1.4 Extraction of Plant Materials with Methanol 
The plant material residue after chloroform extraction was dried overnight and then extracted 
with methanol (CH30H,) using Soxhlet extractor. Dried plant material residues were weighed 
into extraction chamber. Plant material was extracted with 400 ml methanol at the boiling 
point (65° C) using a heating mantle. The condensation rate for the chloroform was set at 
about 60-80 drops per minute and the extraction was continued for 8 hours. After the 
extraction the extract was allowed to cool and filtered with Whatman grade 1: II !lm 
cellulose filter paper. Filtered extract was concentrated by using a hot plate at low 
temperature (40-50° C). Dried extract was weighed and expressed in percentage of original 
sample. All extracts were stored at 4° C until used. 
2.2 Assessment of Antibacterial Activity 
2.2.1 Disk Diffusion Assay for Determination of Antibacterial Activity 
The antibacterial activity test of each extract was carried out by the Kirby-Bauer disk 
diffusion method [170]. For the antibacterial assessment, conventional methods of testing 
antibiotic abilities are usually applied. There are two basic techniques used for the assessment 
of antibacterial activity 
I. The agar diffusion method (paper disc or well), 
2. The dilution method (agar or liquid broth). 
The agar diffusion method is the most widespread teclmique of antibacterial activity 
assessment. The method is recognized as precise and reliable, even though it produces semi-
quantitative results, and according to some authors, only qualitative [171] and not always 
repeatable [172]. Nonethe less, it makes it possible to estimate the degree of microorganism's 
growth inhibition and their morphological changes in a simple way. 
2.2.1.1 Microorganisms 
Three Gram-pos itive clinical isolates - Staphylococcus aureus, Bacillus subtilis, Bacillus 
cereus and three Gram-negative clinical isolates - Escherichia coli, Vibrio cholerae, 
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Salmonella typhi were obtained for agar disk diffusion assay from the Microbiology 
Department of Dhaka University. 
2.2.1.2 Inoculum Preparation 
Stock cultures of bacterial isolates were streaked onto nutrient agar plates and incubated at 
37°C overnight. From overnight subcultures of each isolates, three to five morphologically 
similar colonies were transferred to 5 ml of normal saline, mixed using a vortex mixer. The 
suspension's turbidity was adjusted at 0.08·0.13 measured by a spectrophotometer 
(Shimadzu, Japan) at A. = 625 nm to obtain a bacterial cell concentration of I x I 08 cfulml. 
Turbidity was adjusted by adding sterile normal saline, if the turbidity is too high, or by 
adding more bacterial material if is too low. The inoculum suspension was used within 15 
min of preparation. 
2.2.1.3 Agar Disk Diffusion 
Methanol and chloroform extracts were redissolved into the respective solvents and mixed 
using a vortex mixer. The plant extract so lutions were filtered using a O.22~m Millex 
Millipore filters (Carrigtwohi ll , Ireland). Sterile filter paper disks of 6 mm diameter were 
impregnated with 25 ~I, 50 ~I and 75 ~I of extract solution to produce three disks for each 
plant extracts equivalent to 0.5, I and 1.5 mg of the dried extract respectively. Disks were 
dried for 6 hours to allow complete evaporation of solvent. 
Suspension of each bacterial iso late was inoculated onto the MHA plate by dipping a cotton 
swab into the suspension and streaking over the surface of the plates to create a confluent 
lawn of bacterial growth. The inoculated plate is allowed to dry with the lid left ajar for no 
more than IS min. Using sterile forceps the discs were placed onto the agar surface gently 
pressed down to ensure contact. Plates were kept for 2 hours in refrigerator to enable 
prediffusion of the extracts into the agar. Then the plates were incubated overnight at 37°C. 
Kanamycin (30 ~g) was used as positive control. Negative controls were performed with 
paper discs loaded with organic solvents (chloroform and methanol) and dried. At the end of 
the incubation period the antibacterial activity was evaluated by measuring the inhibition 
zones. 
2.2.2 Agar Well Diffusion for Determination of Antibacterial Activity 
In the burn arena, prior to the advent of topical antibacteri al agents, the overall mortality rate 
in a typical burn population would be reported a 38% to 45%. However after the use of 
topical antibacterial therapy the overall mortality was reduced to 14% to 24%. [173] This 
enhanced survival was probably due to a susceptibility assay developed at the Cincinnati 
Shriners Bums Hospital in 1978 by Nathan and his colleagues [174] called Nathan ' s Agar 
Well Diffusion Assay. This assay has become the "gold standard" among many bum centers 
throughout the world [175]. 
2.2.2.1 Microorganisms 
Three Gram-positive clinical isolates - Staphylococcus aureus, Bacillus subtilis, Bacillus 
cereus and three Gram-negative clinical isolates - Escherichia coli, Vibrio cholerae, 
Salmonella typhi were obtained for agar well diffusion assay from the Microbiology 
Department of Dhaka University. 
2.2.2.2 Inoculum Preparation 
Stock cultures of bacterial isolates were streaked onto nutrient agar plates and incubated at 
37°C overnight. From overnight subcultures of each isolates, three to five morphologically 
similar colonies were transferred to 5 ml of normal saline, mixed using a vortex mixer. The 
suspension 's turbidity was adjusted at 0.08-0.13 measured by a spectrophotometer 
(Shimadzu) at A. = 625 nm to obtain a bacterial cell concentration of I x I 08 cfulml. Turbidity 
was adjusted by adding sterile normal saline, if the turbidity is too high, or by adding more 
bacterial material if is too low. The inoculum suspension was used within IS min of 
preparation. 
2.2.2.3 Agar Well Diffusion 
Methanol and chloroform extracts were dissolved into the respective solvents and mixed 
using a vortex mixer. The plant extract solutions were filtered using a 0.221lm Millex 
Millipore filters (Carrigtwohill, Ireland). 
By sterile technique, 6 mm wells were made on MHA plates. Suspension of each bacterial 
isolate was inoculated onto the MHA plate by dipping a cotton swab into the suspension and 
streaking over the surface of the plates to create a confluent lawn of bacterial growth. The 
inoculated plate is allowed to dry with the lid left ajar for no more than 15 min. Using sterile 
micropipette, wells were loaded with 25 Ill , 50 III and 75 III of extract solution to produce 
three well for each plant extracts equivalent to 0.5 mg, I mg and 1.5 mg of the dried extract 
respectively. Plates were kept for 2 hours in refrigerator to enable prediffusion of the extracts 
into the agar. Then the plates were incubated overnight at 37°C. Kanamycin was used as 
positive control. Negative controls were performed with wells loaded with organic solvents 
(chloroform and methanol). At the end of the incubation period the antibacterial activity was 
evaluated by measuring the inhibition zones. 
2.2.3 MIC Determination by Broth Microdilution 
2.2.3.1 Microorganisms 
The following microorganisms were used in this study: Escherichia coli 0157:H7 and 
clinical isolate of Staphylococcus aureus were obtained from Microbiology Department of 
The University of Dhaka. 
2.2.3.2 Inoculum preparation 
Stock cultures of bacterial isolates were streaked onto nutrient agar plates and incubated at 
37°C overnight. From overnight subcultures of each isolates, three to five morphologically 
similar colonies were transferred to 5 ml of Muller-Hinton broth, mixed using a vortex mixer. 
The suspension 's turbidity was adjusted at 0.08-0.13 measured by a spectrophotometer 
(Shimadzu, Japan) at A = 625 nm to obtain a bacterial cell concentration of I x I 08 cfulml. 
Turbidity was adjusted by adding sterile Muller-Hinton broth, if the turbidity is too high, or 
by adding more bacterial material if is too low. The turbidity adjusted so lution was diluted by 
a factor of I :100 by adding 500 III bacterial suspension to 49.5 m] sterile MHB to achieve a 
concentration of I x I 06 cfulml. 
2.2.3.3 Microtiter plate assay 
Methanol extracts of the plants were dissolved in MHB containing 5% DMSO to obtain a 
concentration of 2mglml and sterilized using a 0.221lm Millex Millipore filters 
(Carrigtwohill, Ireland). Sterilized methanol extract solutions were stored at _20° C until 
used. Ampicillin solution of 2mg/ml was prepared in the similar manner. 
Row A, B, C and D of a sterile 96-well microtiter plate was used to determine MIC of 
Adiantum capillus-veneris, Blumea lacera, Cassia alata and Cissus quadrangulari 
respectively against one bacterial isolates. Row E is used for the positive control Ampicillin. 
Colwnn II & 12 were used as growth control well & sterility control well respectively. 
200 III of MHB containing 5% DMSO was pi petted into sterility control wells (column 12) 
and 100 III into growth control wells. 100 III of 5% DMSO in MHB was added to each well 
of I to 10 columns. 100 III sterilized methanol extract solutions were pi petted into wells of 
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colwnn I for respective plants. After proper mixing 100 fll of the mixture was transferred 
from wells of column I to wells of column 2. The process was repeated with a multichannel 
pipette until column 10 was reached from where 100 fll of the mixture was discarded to 
achieve a final volume of 100 fll in each wells of column I to 10 of row A to D. Wells of 
column I to 10 of row E was similarly filled with ampicillin solution. 100 fll of I x I 06 cfulml 
bacterial suspension was pipetted into each well of column I to II of row A to E, making the 
final volume of each well 200 fll. The final concentration of bacteria in each well was 5x l05 
cfulml and the concentration of extracts ranged between 1000 to 1.953 flglml. Plates were 
then incubated at 37°C for overnight. After incubation, the MIC of each extract was 
determined as the lowest concentration at which no growth was observed. 
2.3 Determination of Antioxidant Activity of Methanol Extracts 
The DPPH free radical scavenging assay was carried out for the evaluation of the antioxidant 
activity. This assay measures the free radical scavenging capacity of the investigated extracts. 
DPPH is a molecule containing a stable free radical. In the presence of an antioxidant, which 
can donate an electron to DPPH, the purple color typical for free DPPH radical decays, and 
the absorbance change at A. = SI7 nm is measured. This test provides information on the 
abi li ty of a compound to donate a hydrogen atom, on the nwnber of electrons a given 
molecule can donate, and on the mechanism of antioxidant action. The method was carried 
out as previously described by Brand et al. [176]. The methanol extracts of four plants 
(Adiantum capillus-veneris, Blumea lacera, Cassia alala and Cissus quadrangularis) were 
redissolved in methanol and various concentrations (10, 50, 100, 500 and 1000 flglml) of 
each extract were used. Similar concentrations of ascorbic acid, propyl galate and BHT were 
used as positive control. The assay mixture contained in a total volwne of I ml, SOO fll of the 
extract, 12S fll prepared DPPH ( I mM in methanol) and 375 fll solvent (methanol) . After 30 
min incubation at 2SoC, the decrease in absorbance was measured at A. = SI7 lun. 
The radical scavenging activity was calculated from the equation: 
% of radical scavenging activity = Abscontrol - AbssamplJ Abscontrol x 100 
1 t 
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2.4 Toxicological evaluation 
Application of in vitro techniques to the assessment of cytotoxic potential in drug 
development continues to be a rapidly growing area. The use of continuous cell lines is an 
important component in this discovery process and may provide fundamental information 
about in vivo xenobiotic toxicity [177]. 
2.4.1 Cell Culture 
The toxicity of methanol plant extracts was examined on distal kidney (MDCK) cell line. 
MDCK cell line, provided by the Microbiology Laboratory of University of Dhaka, was 
cultured in DMEM (Sigma Aldrich) supplemented with 200 mM of glutamine, 10% of feta l 
bovine serum (Sigma), 3.7g1L NaHC03 (Merck), 20mM HEPES, 50 ~g1ml Penicillin, SO 
~g1ml Streptomycin and SO ~g1ml Gentamycin. The cultures were maintained in 37°C in 5% 
of humidity CO2 atmosphere. After 60% - 80% confluence, the cells were trypsinized with 
0.25% Trypsin, counted and passaged. 
2.4.2 Morphological Study 
Methanol extracts were dissolved in 1% DMSO and sterilized using 0.22~m Millex Millipore 
filter. Sterilized methanol extract solutions were stored at _200 C until used. MDCK cells 
suspended in DMEM (Sigma) containing 10% heat-inactivated fetal calf serum were cultured 
in 96-Well flat bottom Microtiter plate (Iwaki, SciTech) at a density of 105 cell/well in the 
presence of S% CO2 at 37°C. 
The cells are then treated with 37.S, 7S, ISO ~g1ml of methanol extracts dissolved in DMSO 
and incubated for 24 h. Untreated cells receiving only media were used as control. After the 
treatment period, morphological observations were made with an inverted phase contrast 
microscope using standard criteria for non-specific cytopathological effects (i.e. membrane 
bleb formation, cell detachment, cellular crenation and cell lysis). Viable MDCK cell s 
retained normal shape, size and attachment as a complete monolayer toxic effect of methanol 
extract and was characterized by cell detachment with the appearance of floating, rounded 
cells and debris [178]. 
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CHAPTER 3 
RESULTS and DISCUSSION 
3.1 Results 
3.1.1 Collection and Extraction of Plant Material 
Records of the collected plants are adapted in table 3. 1 presenting the habit and habitat of the 
plants. Plant materials extracted with Soxhlet extractor are presented in table 3.2 showing % 
yield of the different plant extract. 
3.1.2 Antibacterial Activity 
Antibacterial activity of the plant extracts was screened using, the Kirby-Bauer disk diffusion 
method and Nathan 's agar well diffusion assay. In add ition to that, MIC of plant methanol 
extracts was determined by broth microdilution assay [179] using 96-well microtiter plate. 
The results of disk diffusion assay, agar well diffusion assay, and broth microdilution assay 
are recorded in table 3.3, 3.4 and 3.5. 
No zone of inhibition was observed for any extracts in disk diffusion assay using different 
concentrations of disks against either Gram-positive or Gram-negative isolates. No inhibition 
was also observed for disks loaded with the solvent (negative control). However, kanamycin 
disks of 30 Jlg (positive control) showed strong inhibition against every Gram-positive or 
Gram-negative isolates. 
No zone of inhibition was observed for any extracts in agar well diffusion assay usmg 
different concentrations of extract loaded in each well against either Gram-positive or Gram-
negative isolates. No inhibition was also observed for wells loaded with the solvent (negative 
control). However, wells laden with kanamycin solution (30 Jlglwell) (positive control) 
exhibited strong inhibition against every Gram-positive or Gram-negative isolates. 
No inhibition was seen for any methanol extracts of different concentrations used against 
Staphylococcus aureus isolate and Escherichia coli 0157:H7 strain for the determination of 
MIC. However, no growth was noted in the wells loaded with Ampici llin (positive control). 
No growth was observed for the wells of column 12 (sterility control) whereas di stinct 
growth was observed in the wells of column II (growth control). 
3.1.3 Radical scavenging activity 
The methanol extracts of Adiantum capillus-veneris, Blumea lacera, and Cassia alala 
showed a highly effective free radical scavenging activity in the DPPH assay. These extracts 
exhibited a noticeable antioxidant effect at low concentrations compared with the standards 
(Table 3.6). The methanol extracts of Cissus quadrangularis demonstrated moderate free 
radical scavenging activity with diminutive antioxidant activity at lower concentration and 
high antioxidant activity at increasing concentration. 
3.1.4 Cytotoxic activity 
Toxicological evolution of methanol extracts was performed by in vitro cytoxicity assay 
against MDCK cell line. Morphological study of methanol extract treated MDCK cell under 
inverted phase contrast microscope revealed the viabi lity. MDCK cultures treated with 
different concentrations of Adiantum capillus-veneris, Blumea lacera, and Cassia a/ata 
methanol extract demonstrated the characteristics of dead cell s with disappearance of 
monolayer and normal shape and size, cell detachment, presence of floating, rounded cells 
and debris. This designates the toxic effect of Adiantum capillus-veneris, Blumea lacera, and 
Cassia alata methanol extract on MDCK cells at the investigated concentration. The 
methanol extract of Cissus quadrangular is, on the other hand, provided viable condition for 
the growth of MDCK cell as it demonstrates similar appearances to that of untreated MDCK 
control. 
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Table 3.1 Plant Collection Records 
Plant Plant's Scientific Location of Tropology Abundance Plant Leaf type 
No. Local Name Name Collection T.n~e 
I. Bidhayapata Adiantum Faridpur, Plains Occasional Herb Light green fronds 
capillus-veneris Bangladesh much subdivided into 
~mnae 
2. Kukursunga Blumea lacera Faridpur, Plains Abundant Herb Lower leaves incised or 
Bangladesh lyrate, the upper oblong 
or obovate, finely silky 
~ubescut 
3. Dadmadan Cassia alala Faridpur, Plains Very few Shrub Leaves glandular with a 
Bangladesh prominent transverse 
ridge connecting the 
o~~osite leaflets 
4. Harjoda Cissus Faridpur, Plains Occasional Herb Toothed trilobe leaves 
quadrangularis Bangladesh appear at the nodes, has 
a tendril emerging 
Table 3.2 Percent yield of different plant material extraction 
Plant Family Parts used Extract % yield 
Adianlum capillus-veneris Pteridaceae Whole plant Chloroform 2.8 
Methanol 13 .3 
Blumea lacera Compositae Leaves Chloroform 4.4 
Methanol 13.6 
Cassia aiala Caesalpiniaceae Leaves Chloroform 5.6 
Methanol 14.8 
Cissus quadrangularis Vitaceae Whole plant Chloroform 2.1 
Methanol 6.3 
Date of 
Collection 
15/01 /2010 
16/0112010 
16/0112010 
15/01 /2010 
Time of 
Collection 
Morning 
Morning 
Morning 
After noon 
35 
L 
" 
Adiantum capillus-veneris (Bidhayapata) B/umea /acera (Kukursunga) 
Cissus quadrangularis (Harjoda) 
Cassia a/ala (Dadmadan) 
Figure 3.1 Pictures of the collected pants 
36 
Table 3.3 Antibacterial activity of plant extracts observed in disk diffusion assay expressed in terms of zone of inhibition (mm) 
Evaluated Item 
Adiantum capillus-
veneris 
Blumea lacera 
Cassia alata 
CissllS quadrangularis 
Extract 
Ch loroform 
Methanol 
Chloroform 
Methanol 
Chloroform 
Methanol 
Chloroform 
Methanol 
Concentration 
per disk 
0.5 mg 
1.0mg 
1.5 mg 
0.5 mg 
1.0mg 
1.5 mg 
0.5 mg 
1.0mg 
1.5 mg 
0.5 mg 
1.0mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0mg 
1.5 mg 
Kanamycin (+ Control) nla 30 fig 
Chloroform (- Control) nla 5 ml 
Methanol (- Control) nla 5 ml 
Zone of Inhibition Against Different Microorganisms in mm 
SA BS BC EC VC ST 
25 28 24 22 23 25 
SA; Staphylococcus aureus, BC; Bacillus cereus, BS; Bacillus sub/ilis, EC; Escherichia coli, VC ; Vibrio cholerae, ST; Salmonella typhi 
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Table 3.4 Antibacterial activity of plant extracts observed in agar well diffusion assay expressed in terms of zone of inhibition (mm) 
Investigated element 
Adiantum capillus-
veneris 
Blumea lacera 
Cassia alala 
Cissus quadrangularis 
Extract 
Chloroform 
Methanol 
Chloroform 
Methanol 
Chloroform 
Methanol 
Chloroform 
Methanol 
Concentration 
per well 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
0.5 mg 
1.0 mg 
1.5 mg 
Kanamycin (+ Control) nla 30 ~g 
Chloroform (- Control) nla 5 ml 
Methanol (- Control) nla 5 ml 
Zone of inhihition against different microorganisms in mm 
SA BS BC EC VC ST 
23 21 21 23 25 21 
SA= Staphylococcus aureus, BC= Bacillus cereus, BS= Bacillus subtilis, EC= Escherichia coli, VC = Vibrio cholerae, ST= Salmonella typhi 
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Table 3.5 Mle of methanol extracts of investigated plants 
Investigated Element 
Adiantum capillus-veneris 
Btllmea lacera 
Cassia aLala 
Cissus quadrangularis 
Ampici ll in 
MIC against different microorganisms (Ilglml) 
Escherichia coli 0157:H 7 Staphy lococcus aureus 
1.953 !1glml 1.953 Jlg/ml 
Table 3.6 Free radical scavenging activity of methanol extracts of investigated plants 
Investigated Element 
Adiantum capillus-veneris 
Bll/mea lacera 
Cassia a/ala 
Cissus quadrangularis 
Ascorbic Acid (Standard) 
BHT (Standard) 
Propyl Gallate (Standard) 
100.00 
~ 
'> 
.. 80.00 u 
< 
.. 
c 
'iiQ 60.00 c 
~ 
.. 
u 
'" iii 40.00 
u 
=a 
.. 
'" ~ 20.00 
0.00 
0 200 
% Radical scavenging activity at different concentrations 
10llglmi 50 Ilg/ml 
83.87 79.21 
17.20 52.69 
68.46 76.70 
16. 13 35. 13 
95.34 97.13 
83 .87 94.98 
96.77 98 .92 
400 600 800 
Concentration !l8/ml 
100llglmi 
97.13 
88 .53 
92.11 
43.37 
97.49 
97.13 
99 .28 
1000 
SOO/lg/ml 10001lg/ml 
96.06 88.89 
94.62 94.98 
96.42 84.59 
79.93 85.30 
98.57 99.28 
98.92 99.28 
99.64 100.00 
-1-Ascorbic Add 
~BHT 
__ Propyl Gallate 
~Adiantum capillus-veneris 
~Blumea laeera 
......Cassia alata 
~Cissus quadranguJaris 
Figure 3.2 Free radical scavenging activity of methanol extracts of investigated plants 
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MOCK cells treated with Adiantum capillus-veneris methanol extract of37.5 I'glml (a), 75 I'glml (b) 
and 150 I'glml (c) 
MOCK cells treated with Blumea lacera methanol extract of37.5l'glml (d), 75 I'glml (e) and 150 I'glml (I) 
MOCK ceUs treated with Cassia alata methanol extract of37.5l'glml (g), 751'glml (h) and 150 I'glml (i) 
MOCK cells treated with Cissus quadrangularis methanol extract of37.5 I'glml 0), 75 I'glml (k) andl50 
I'glml (k) 
Untreated MOCK control (m) 
Figure 3.3 Micrograpbs of MOCK cultures treated witb metbanol extracts of different 
concentrations 
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3.2 Discussion 
Finding healing powers in plants is an ancient idea. People on all continents have long 
applied poultices and imbibed infusions of hundreds, if not thousands, of indigenous plants, 
dating back to prehistory [40]. A survey by UNCTAD has shown that 33% of total drugs 
produced by the industrialized nations are plant derived and microbes are considered, 60% of 
medicinal products are of natural origin [180]. With the estimated 10- 100 million species or 
organisms living on earth and higher plants forming a group of some 250,000 species out of 
which only 6% has been investigated for biological activities and 15% for their chemical 
constituents, it looks increasingly like we have only scratched the surface of thi s world's 
wonderful resource [181]. Researchers are increasingly turning their attention to folk 
medicine looking for new leads to develop better drugs against cancer, as well as viral and 
microbial infections [182, 183]. Presently, there has been an amplified interest worldwide to 
identify antioxidant compounds which are pharmacologically effective and have low or no 
side effects for use in preventive medicine and the food industry [184]. 
In continuance of the search for plants with pharmacological effects, this study has screened 
four plants collected from Faridpur, Bangladesh for antibacterial and antioxidant activities as 
well as their potential toxicological activity. Identification of the investigated plants was done 
by Bushra Khan and Ahsan Habib (Scientific Officers) from Bangladesh National Herbarium, 
Dhaka, Bangladesh. The existing knowledge about the investigated plants is in many cases is 
very limited. 
Investigated plant parts were extracted with Soxhlet extraction procedure, provided 
productive yield with the highest yield for methanol extract was 14.8% and the highest yield 
for chloroform extract was 5.6%. 
Adiantum Linn. of Adiantaceae family is one of the most common and widely distributed 
species. Ethnomedicinally, the genus is important and popularly known as "Hansraj" in 
Ayurvedic System of Medicine. It has been used in cold, tumors of spleen, liver and other 
viscera, skin diseases, bronchitis and inflammatory diseases. Its leaves are also considered as 
expectorant tonic [185]. In current study, no antibacterial activity of Adiantum capillus-
veneris was demonstrated against any of the Gram positive or Gram negative isolates used for 
the evaluation. However, methanol extract of Adiantum capillus-veneris has previously 
'tl 
demonstrated inhibition against five Gram positive and Gram negative E. coli strains and the 
activity was concluded due to the presence of flavonoid and tannin along with reducing sugar 
[ 185]. 
Adiantum capillus-veneris showed antioxidant activity at a very low concentration (10!!giml) 
as it was also previously reported [186, 187]. However, previous report required high 
concentration (4mg/ml) of Adiantum capillus-veneris extract to demonstrate obtrusive 
activity and recognized due to the presence of flavonoid and phenol. Our study also confirms 
cytotoxic activity of Adiantum capillus-veneris against noncancerous MDCK cell line. No 
previous record on toxicological evaluation of Adiantum capillus-veneris was found . 
Blumea lacera is a common weed found throughout the Bangladesh. The leaves of the plant 
are anthelmintic, febrifuge , and astringent. The plant is a diuretic, antiscorbutic, and useful in 
catarrhal affections [188]. Our study was unable to demonstrate the presence of any 
antibacterial activity in Blumea lacera activity against the screened organism. Although, 
previous records shows antibacterial activity of Bilimea lacera extracts against Gram positive 
or Gram negative microorganisms accounted to the existence of monoterpene glycoside and 
flavonoids [188, 189]. Bilimea lacera displayed antioxidant function at low concentration (50 
!!g/ml) as it was previously reported. Bilimea lacera also expressed toxic activity against 
MOCK cell line. Similar cytotoxicity of Bilimea lacera against noncancerous mouse 
fibroblasts cell line was previously observed [190]. 
Cassia alata is often called the Ringworm Bush because of its very effective fungicidal 
properties, for treating ringworm and other fungal infections of the skin. Its active ingredients 
include the yellow chrysophanic acid. Its laxative effect, due to its anthraquinone content, is 
also well proven. Extracts of Cassia alata were also incapable to express any antibacterial 
activity in our study. Similar observation was previously reported, where Gram positive and 
Gram negative bacterial species showed resistance against ethanolic extract of Cassia alata in 
disk diffusion assay using 500 mg extract-impregnated disks [191]. Nevertheless, other study 
reported antibacterial activity of methanol and ethanol extract of Cassia alata against Gram 
positive and Gram negative bacterial species when extracts were used at a much lower 
concentrations [192, 193]. Methanol extracts of Cassia alata showed free radical scavenging 
activity at minute concentration (lO!!g/ml). Comparable observation was also previously 
reported [194, 195]. Cassia alata expressed toxic activity against MDCK cell line activity in 
A') 
our study. In other report, however, Cassia alata isolate showed no cytotoxicity to the normal 
ce ll line, CHO-AA8 [196]. 
Cissus quadrangularis grows in the Sundarbans and occasionally planted in the gardens in 
others areas [54]. The plant is mentioned in the ancient systems of medicine such as 
Ayurveda, and is useful for treatment of bloody diarrhoea, skin disorders, earache, 
haemorrhoids, irregular menstruation, and accelerates healing of bone fracture [197]. Cissus 
quadrangularis extracts conferred no antibacterial activity towards the examined Gram 
positive and Gram negative bacterial species, although earlier report indicates the presence of 
antibacterial activity in ethyl acetate, acetone, and methanol extract of Cissus quadrangularis. 
Methanol extracts of Cissus quadrangularis also showed progressive antioxidant activity. In 
earlier report, less significant antioxidant activity was recorded in methanol extracts of Cissus 
quadrangularis [198]. Toxicological evaluation demonstrates no cytotoxic action of methanol 
extract of Cissus quadrangularis against noncancerous MOCK cell line. At our best notice no 
such previous records of cytotoxicity for Cissus quadrangular is was reported. However, in 
one subchronic toxicity investigation Cissus quadrangularis did not produce any toxicity in 
the rats [199]. 
In summary, antibacterial and antioxidant potential of four selected medicinal plant was 
investigated in the present study. To assist the potential development of the medicinal plants 
as dietary supplement or therapeutic agent, toxicological evaluation of the plants was also 
apprehended. Although, disparate to previous investigations, no antibacterial activity was 
observed in the methanol and chloroform extracts of the investigated plants. This variation in 
the results may indicate a number of dissimilarities in the apprehended study from the 
previous studies including environmental effects on the studied plant, age of the plant 
therefore presence of active substance, season for plant collection, method of extraction used, 
time of extraction, method of antibacterial susceptibi lity assay, different concentrations of 
extracts used during the assay, and other reasons associated to medicinal plant research. In 
contrast, methanol extracts of investigated plants demonstrate effective antioxidant action and 
warrant for further study to identify and isolate the compounds responsible for free radical 
scavenging activity. Methanol extracts of Adiantum capillus-veneris, Blumea lacera, and 
Cassia alata exhibited cytotoxic activity against distal kidney (MOCK) cell line indicating 
their potential harmful effect on mammalian kidney. No such cytotoxic effect was observed 
for Cissus quadrangularis referring to their relative nontoxic aspect towards mammalian 
kidney, although more toxicological study IS required to declare them safe for potential 
development. 
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